# Margot Tesselaar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/margot-tesselaar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,997 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 40 |
| i10-index | 86 |
| Last Known Institution | Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital |
| OpenAlex ID | https://openalex.org/A5005729270 |
| ORCID iD | 0000-0002-8885-4638 |
| Works | 182 |

## Researcher papers

- [Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-for-the-treatment-of-advanced-non-functional-neuroendocrine-tumours/)
- [Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial](https://scholariq.org/papers/sequential-versus-combination-chemotherapy-with-capecitabine-irinotecan-and/)
- [Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?](https://scholariq.org/papers/microparticle-associated-tissue-factor-activity-a-link-between-cancer-and/)
- [Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy](https://scholariq.org/papers/phase-3-randomized-trial-on-larynx-preservation-comparing-sequential-vs/)
- [Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial](https://scholariq.org/papers/neo-adjuvant-chemotherapy-for-operable-gastric-cancer-long-term-results-of-the/)
- [Deep vein thrombosis associated with central venous catheters – a review](https://scholariq.org/papers/deep-vein-thrombosis-associated-with-central-venous-catheters-a-review/)
- [Microparticle-associated tissue factor activity in cancer patients with and without thrombosis](https://scholariq.org/papers/microparticle-associated-tissue-factor-activity-in-cancer-patients-with-and/)
- [European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for digestive neuroendocrine carcinoma](https://scholariq.org/papers/european-neuroendocrine-tumor-society-scp-enets-scp-2023-guidance-paper-for/)
- [European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease](https://scholariq.org/papers/european-neuroendocrine-tumor-society-scp-enets-scp-2022-guidance-paper-for/)
- [Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature](https://scholariq.org/papers/prognostic-value-of-resection-of-primary-tumor-in-patients-with-stage-iv/)
- [Four decades of experience with carcinoid heart disease: An analysis of 84 patients](https://scholariq.org/papers/four-decades-of-experience-with-carcinoid-heart-disease-an-analysis-of-84/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.